Adjuvant pretreatment with alum protects neonatal mice in sepsis through myeloid cell activation
- 16 November 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 191 (3), 268-278
- https://doi.org/10.1111/cei.13072
Abstract
The high mortality in neonatal sepsis has been related to both quantitative and qualitative differences in host protective immunity. Pretreatment strategies to prevent sepsis have received inadequate consideration, especially in the premature neonate, where outcomes from sepsis are so dismal. Aluminium salts-based adjuvants (alum) are used currently in many paediatric vaccines, but their use as an innate immune stimulant alone has not been well studied. We asked whether pretreatment with alum adjuvant alone could improve outcome and host innate immunity in neonatal mice given polymicrobial sepsis. Subcutaneous alum pretreatment improves survival to polymicrobial sepsis in both wild-type and T and B cell-deficient neonatal mice, but not in caspase-1/11 null mice. Moreover, alum increases peritoneal macrophage and neutrophil phagocytosis, and decreases bacterial colonization in the peritoneum. Bone marrow-derived neutrophils from alum-pretreated neonates produce more neutrophil extracellular traps (NETs) and exhibit increased expression of neutrophil elastase (NE) after in-vitro stimulation with phorbol esters. In addition, alum pretreatment increases bone marrow and splenic haematopoietic stem cell expansion following sepsis. Pretreatment of neonatal mice with an alum-based adjuvant can stimulate multiple innate immune cell functions and improve survival. These novel findings suggest a therapeutic pathway for the use of existing alum-based adjuvants for preventing sepsis in premature infants.Funding Information
- NIGMS (R01 GM-097531, P50 GM-111152, K08 GM-106143)
This publication has 42 references indexed in Scilit:
- Particulate Adjuvant and Innate Immunity: Past Achievements, Present Findings, and Future ProspectsInternational Reviews of Immunology, 2013
- Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000The Lancet, 2012
- Pathophysiology and Treatment of Septic Shock in NeonatesClinics in Perinatology, 2010
- Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, But These Sensors Are Not Required for Alum to Act As an Adjuvant for Specific ImmunityThe Journal of Immunology, 2009
- Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonatesBlood, 2009
- Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonistsBlood, 2008
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cellsThe Journal of Experimental Medicine, 2008
- CD40 and CD80/86 Act Synergistically to Regulate Inflammation and Mortality in Polymicrobial SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Caspase-1 RegulatesEscherichia coliSepsis and Splenic B Cell Apoptosis Independently of Interleukin-1β and Interleukin-18American Journal of Respiratory and Critical Care Medicine, 2006
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004